America December 18, 2020
Biogen to pay $22M to settle lawsuit over kickback scheme involving its multiple sclerosis drugs
Biogen Inc (NASDAQ: BIIB) agreed to pay $22 million to settle a lawsuit alleging it committed unlawful conduct involving its…
America December 18, 2020
Biogen Inc (NASDAQ: BIIB) agreed to pay $22 million to settle a lawsuit alleging it committed unlawful conduct involving its…
By Marivic Cabural Summers